Manufacturer:
Genentech
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Approved Indication:
prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogenic kidney, heart, or liver transplants, in combination with other immunosuppressants
Conditions:
- Solid Organ Transplant
Therapeutic Area:
- Gastroenterology
- Rheumatology
- Dermatology
- Hepatology
- Nephrology